Robert L. Rosiello
Valeant Pharmaceuticals International
Executive Vice President and Chief Financial Officer
|Non-Equity Incentive Plan||$712,184|
In 2015, Robert L. Rosiello earned a total compensation of $60,398,398 as Executive Vice President and Chief Financial Officer at Valeant Pharmaceuticals International, Inc..
Rosiello received $53,126,290 in stock awards, which accounts for 87.96% of total compensation.
Rosiello also received $6,000,000 in bonus, $712,184 in non-equity incentive plan, $546,154 in salary and $13,770 in other compensation.